Une candidature complète en une minute — CV personnalisé et lettre de motivation, prêts à envoyer.
CSL Seqirus seeks an Associate Director, Market Access and Business Development to lead market access and commercial growth across the Nordics and Benelux. The role partners with health authorities, payers and policymakers to drive patient access and business performance, reporting to the Country Head, Nordics & Benelux.
You will craft value propositions, manage tenders, and work with cross-functional teams to expand CSL Seqirus' portfolio in the region within a hybrid work setup (Amsterdam,
We are seeking an Associate Director, Market Access and Business Development to lead CSL Seqirus' market access and commercial growth initiatives across the Nordics and Benelux. This newly created strategic role reports to the Country Head, Nordics & Benelux and will play a pivotal role in driving the successful establishment, expansion, and long-term growth of the CSL Seqirus portfolio across the region.
The Associate Director, Market Access and Business Development is responsible for developing and executing market access strategies that enable sustainable growth of the CSL Seqirus portfolio across the Nordics and Benelux. The role combines strategic market access leadership with business development, stakeholder engagement, tender management, and cross-functional collaboration to maximise commercial opportunities and strengthen CSL Seqirus' position within the healthcare landscape.
Working closely with internal and external stakeholders, the role will build long-term partnerships with health authorities, reimbursement bodies, policymakers, healthcare providers, and key opinion leaders while supporting policy initiatives, pricing and reimbursement activities, and commercial strategies that improve patient access and drive business performance.
This role can be based in Amsterdam, Netherlands (preferred), Copenhagen, Denmark, or Mechelen, Belgium, operating within a hybrid working model that combines office-based and remote work.